HIV status disclosure to adolescents living with Human Immunodeficiency Virus (ALHIV) is essential for adherence to ART treatment and psychosocial well‑being yet it remains delayed in high‑burden settings. This study examined the rate and timing of HIV status disclosure and identified individual, familial, and socio-cultural determinants influencing HIV status disclosure to adolescents in Western Kenya. A convergent parallel mixed?methods design was used. Quantitative data were collected from 310 caregivers of ALHIV aged 10–19 years attending three health facilities in Bondo Sub?County using structured questionnaires. Qualitative data were obtained through eight focus group discussions (64 caregivers) and 10 key informant interviews with healthcare providers. Quantitative data were analysed using multivariate logistic regression with quadratic age terms, while qualitative data were analysed thematically. Integration was achieved through joint displays and a weaving approach. The HIV status disclosure rate was 74.5%, yet disclosure was delayed in early adolescence: only 1.8% of adolescents aged 10–12 years had been disclosed to, compared with 60.5% of those aged 13–14 years and 96.3% of those aged 15–19 years (mean disclosure age: 11.8 years). Age demonstrated a strong non?linear association with disclosure (quadratic aOR = 0.70, 95% CI: 0.59–0.83; p < 0.001). Independent predictors of disclosure included caregiver training the strongest modifiable determinant (aOR = 15.61)—caregiver confidence in discussing HIV (aOR = 2.42), access to adolescent peer support groups (aOR = 3.33), facility of care (aOR = 2.96), and perceived adolescent emotional maturity (aOR = 1.52), while fear of psychological distress emerged as the dominant barrier (aOR = 0.27). Although 34.6% of adolescents experienced initial distress following disclosure, 93.9% demonstrated improved ART adherence and 92.6% improved emotional well-being. Findings showed HIV disclosure decisions depended on caregiver capacity and health system support. In Western Kenya, adolescent disclosure remains delayed beyond guideline recommendations, with age serving as a threshold. Effective disclosure requires alignment between adolescent emotional readiness, caregiver preparedness, and supportive health system structures. An evidence-based disclosure guide was developed comprising three-core components: readiness-based assessment integrated with caregiver capacity building, family-engaged disclosure planning, and health-system enabling with structured post-disclosure support. This framework reconceptualises HIV disclosure from an age-driven expectation to a system-dependent process. There is need to implement structured HIV disclosure approaches that integrate readiness-based assessment, systematic caregiver capacity building, and strengthened adolescent peer support systems. Disclosure should be initiated earlier through individualised, and informed planning. Lastly, trauma-informed post-disclosure follow-up should be embedded within routine care to address initial distress and sustain improvements in adherence and emotional well-being.
| Published in | Social Sciences (Volume 15, Issue 4) |
| DOI | 10.11648/j.ss.20261504.14 |
| Page(s) | 181-195 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2026. Published by Science Publishing Group |
HIV Status Disclosure, Adolescents, Caregivers, Western Kenya, Mixed-methods, Disclosure Guide, Implementation Science, Evidence-based Intervention
Region/Country | Number of Studies | Percentage |
|---|---|---|
Kenya (Total) | 58 | 37.2% |
Western Kenya | 31 | 19.9% |
Other Kenyan regions | 27 | 17.3% |
Uganda | 24 | 15.4% |
Tanzania | 19 | 12.2% |
South Africa | 22 | 14.1% |
Other Sub-Saharan African countries | 33 | 21.1% |
Total | 156 | 100% |
Country/Region | Pooled Disclosure Rate | Range | Number of Studies |
|---|---|---|---|
Kenya (national) | 46.3% | 28–72% | 18 |
Western Kenya | 41.7% | 20–60% | 12 |
Uganda | 43.2% | 25–68% | 15 |
Tanzania | 39.8% | 21–58% | 12 |
South Africa | 52.4% | 35–78% | 14 |
Other SSA countries | 44.6% | 24–71% | 21 |
Disclosure status | Frequency | Percent |
|---|---|---|
No | 79 | 25.5 |
Yes | 231 | 74.5 |
Total | 310 | 100 |
Disclosure Status | 10-12yr | 13-14yr | 15-19yr | Total |
|---|---|---|---|---|
No | 56 (98.2%) | 15 (39.5%) | 8 (3.7%) | 79 (25.5%) |
Yes | 1 (1.8%) | 23 (60.5%) | 207 (96.3%) | 231 (74.5%) |
Total | 57 | 38 | 215 | 310 |
Variable | Disclosure status (yes,%) | P value | Chi, (t-test) |
|---|---|---|---|
Caregiver demographics | |||
Gender (Female) | 184 (74%) | 0.794 | 0.0679 |
Age in years- [mean, range] | 45 [20-76] | <0.001 | t = -5.1982 |
Marital Status | |||
Single | 30 (61%) | 0.002 | 17.2402 |
Married/Cohabiting | 120 (78%) | ||
Divorced | 8 (53%) | ||
Widowed | 61 (86%) | ||
Separated | 12 (57%) | ||
Level of education | |||
None | 20 (77%) | 0.853 | 1.0476** |
Primary | 119 (76%) | ||
Secondary | 69 (73%) | ||
College/Tertiary | 22 (73%) | ||
University | 1 (50%) | ||
Religion | |||
Christian | 229 (74%) | 0.555 | 0.6884** |
Muslim | 2 (100%) | ||
Occupation | |||
None | 12 (75%) | 7.932 | 0.094 |
Farming | 94 (77%) | ||
Employed | 34 (79%) | ||
Business | 73 (76%) | ||
Others | 18 (54%) | ||
Variable | Disclosure (yes,%) | P value | Chi |
|---|---|---|---|
Sex | |||
Female | 137 (75%) | Ref | Ref |
Male | 94 (73%) | 0.715 | 0.1336 |
Age in years | |||
10-12 | 1 (1.8%) | <0.001 | 216.45 |
13-14 | 23 (60.5%) | ||
15-19 | 207 (96.3) | ||
Level of education | |||
Primary | 57 (44%) | <0.001 | 136.2102 |
Secondary | 174 (99%) | ||
None | 0 (0%) | ||
Received formal education | |||
Yes | 200 (97%) | <0.001 | 185.9349 |
Not sure | 21 (51%) | ||
No | 10 (16%) | ||
Who disclosed HIV status? | Frequency | Percent |
|---|---|---|
Caregiver | 165 | 71.4 |
Discovered on their own | 8 | 3.5 |
Healthcare Provider | 57 | 24.7 |
Others | 1 | 0.4 |
Total | 231 | 100 |
Reason | Frequency | Percent |
|---|---|---|
Fear of emotional distress | 10 | 12.7 |
Fear of stigma | 18 | 22.8 |
Lack of knowledge | 10 | 12.7 |
Other | 1 | 1.2 |
Too young | 40 | 50.6 |
Total | 79 | 100 |
Variable | Median (IQR)- Disclosed No (n=79) | Median (IQR)- Disclosed Yes (n=231) | Mean rank (No) | Mean rank (Yes) | Mann Whitney U | Z | p value |
|---|---|---|---|---|---|---|---|
Adolescent's age influences my decision to disclose | 4 (4-5) | 4 (2-4) | 189.5 | 143.9 | 6440 | 4.186 | <0.001 |
Adolescent's perceived maturity influences my decision to disclose | 4 (2-4) | 4 (2-4) | 162.8 | 153 | 8552 | 0.885 | 0.376 |
I feel confident discussing HIV with adolescent | 2 (2-4) | 4 (3-4) | 104.6 | 172.9 | 5100 | -6.225 | <0.001 |
My emotional readiness affects my decision to disclose | 4 (3-4) | 4 (2-4) | 179.9 | 147.2 | 7196 | 3.038 | 0.002 |
Family members' opinions influence my decision to disclose | 3 (2-4) | 3 (2-4) | 164.8 | 152.3 | 8393 | 1.115 | 0.265 |
Community stigma discourages me from disclosing | 4 (3-4) | 3 (2-4) | 175.6 | 148.6 | 7536 | 2.456 | 0.014 |
Cultural beliefs influence my decision to disclose | 3 (2-4) | 3 (2-4) | 153.4 | 156.2 | 8960 | -0.249 | 0.803 |
How emotionally mature do you believe adolescent is? | 2 (1-3) | 5 (4-5) | 97.5 | 175.3 | 4546 | -6.96 | <0.001 |
Variable | Disclosed = No (n=79) | Disclosed = Yes (n=231) | Total | P-value |
|---|---|---|---|---|
Has adolescent asked about their illness/medication? | ||||
No | 26 (32.9%) | 37 (16.0%) | 63 | **<0.001 |
Not Sure | 2 (2.5%) | 0 (0.0%) | 2 | |
Yes | 51 (64.6%) | 194 (84.0%) | 245 | |
Do you believe disclosure would improve adolescent ART adherence? | ||||
No | 3 (3.8%) | 11 (4.8%) | 14 | <0.001 |
Not Sure | 22 (27.8%) | 7 (3.0%) | 29 | |
Yes | 54 (68.4%) | 213 (92.2%) | 267 | |
Do you believe adolescent might infect others if not informed? | ||||
No | 20 (25.3%) | 62 (26.8%) | 82 | 0.013 |
Not Sure | 17 (21.5%) | 21 (9.1%) | 38 | |
Yes | 42 (53.2%) | 148 (64.1%) | 190 | |
Do you believe adolescent would face rejection if disclosed? | ||||
No | 23 (29.1%) | 117 (50.6%) | 140 | 0.002 |
Not Sure | 14 (17.7%) | 21 (9.1%) | 35 | |
Yes | 42 (53.2%) | 93 (40.3%) | 135 | |
How do you feel about keeping adolescent's HIV status secret? | ||||
Comfortable | 52 (65.8%) | 110 (47.6%) | 162 | 0.018 |
Not Sure | 11 (13.9%) | 56 (24.2%) | 67 | |
Tired | 16 (20.3%) | 65 (28.1%) | 81 | |
Predictor | Adjusted odds ratio | 95% CI | p value |
|---|---|---|---|
Age (centred at mean ≈ 15.4 years) | |||
Age (centred) | 3.63 | 2.29 - 5.76 | <0.001 |
Age² (centred) | 0.70 | 0.59 – 0.83 | <0.001 |
Ordinal Likert variables (per 1 point increase) | |||
Adolescent’s age influences my decision to disclose | 1.15 | 0.62 – 2.12 | 0.662 |
Confidence discussing HIV with adolescent | 2.42 | 1.31 – 4.47 | 0.005 |
My emotional readiness affects my decision | 1.02 | 0.52 – 2.04 | 0.944 |
Community stigma discourages me from disclosing | 0.69 | 0.37 – 1.28 | 0.236 |
Perceived emotional maturity of adolescent | 1.52 | 1.00 – 2.29 | 0.048 |
Categorical variables (reference = “No”) | |||
Adolescent asked about illness (Yes vs No) | 0.98 | 0.19 – 5.11 | 0.976 |
Disclosure improves ART adherence (Not Sure vs No) | 0.14 | 0.004 – 4.93 | 0.276 |
Disclosure improves ART adherence (Yes vs No) | 0.49 | 0.03 – 7.40 | 0.603 |
Adolescent might infect others (Not Sure vs No) | 0.56 | 0.06 – 5.39 | 0.617 |
Adolescent might infect others (Yes vs No) | 1.82 | 0.39 – 8.51 | 0.444 |
Adolescent would face rejection (Not Sure vs No) | 0.2 | 0.03 – 1.26 | 0.088 |
Adolescent would face rejection (Yes vs No) | 0.82 | 0.20 – 3.44 | 0.788 |
Feeling about keeping status secret (Not Sure vs Comfortable) | 0.64 | 0.12 – 3.45 | 0.601 |
Feeling about keeping status secret (Tired vs Comfortable) | 2.3 | 0.37 – 14.24 | 0.37 |
AIDS | Acquired Immunodeficiency Syndrome |
ALHIV | Adolescents Living with HIV |
aOR | Adjusted Odds Ratio |
ART | Antiretroviral Therapy |
AUC | Area Under the Curve |
CI | Confidence Interval |
EGPAF | Elizabeth Glaser Pediatric AIDS Foundation |
FGD / FGDs | Focus Group Discussion(s) |
HIV | Human Immunodeficiency Virus |
ICC | Intraclass Correlation Coefficient |
IQR | Interquartile Range |
KII / KIIs | Key Informant Interview(s) |
KMO | Kaiser-Meyer-Olkin Measure |
KNBS | Kenya National Bureau of Statistics |
KoboCollect | KoboCollect Data Collection Platform |
NASCOP | National AIDS and STI Control Programme |
NDoH | National Department of Health |
NSDCC | National Syndemic Diseases Control Council |
NVivo | Qualitative Data Analysis Software |
OR | Odds Ratio |
PLoS | Public Library of Science |
PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
Ref | Reference Category |
S-CVI | Scale Content Validity Index |
SSA | Sub-Saharan Africa |
STI | Sexually Transmitted Infection |
TB | Tuberculosis |
TTI | Theory of Triadic Influence |
VIF | Variance Inflation Factor |
WHO | World Health Organization |
| [1] |
WHO. Guideline on HIV disclosure counselling for children up to 12 years of age. 2011; 1–46. Available from:
https://iris.who.int/server/api/core/bitstreams/39c8e7f1-2425-45c0-878f-b83541f573c7/content |
| [2] | WHO. Supporting disclosure among children and adolescents living with HIV: interventions, emerging considerations, key gaps and key actions. Organization CL, Institute for Life Course Health Research, Department of Global Health, Stellenbosch University T, Africa S, editors. Geneva: WHO, Departmental update; 2025. 48 p. Available from: |
| [3] | NASCOP. HIV Prevention and Treatment Package for Adolescents and Young People. 2024; 2: 116. Available from: |
| [4] |
NDoH. Disclosure Guidelines for Children and Adolescents in the context of HIV, TB and non-communicable diseases. x 2020; (July). Available from:
https://www.sahivsoc.org/Files/NDoH_hiv-disclosure-guideline.pdf |
| [5] | Glaser E. Disclosure of HIV status toolkit for pediatric and adolescent populations. Elizab Glas Pediatr AIDS Found Washingt DC. 2016: 1-74. |
| [6] | Krauss BJ, Letteney S, Okoro CN. Why Tell Children: A Synthesis of the Global Literature on Reasons for Disclosing or Not Disclosing an HIV Diagnosis to Children 12 and under. Vol. 4, Frontiers in Public Health. Frontiers Media S. A.; 2019: |
| [7] | Mengesha MM, Teshome A, Ajema D, Tura AK, Hallström IK, Jerene D. The association between HIV diagnosis disclosure and adherence to anti-retroviral therapy among adolescents living with HIV in Sub-Saharan Africa: A systematic review and meta-analysis. PLoS One. 2023; 18(5): e0285571: |
| [8] | NASCOP. Adolescent ’ s Package of Care in Kenya. 2014. |
| [9] | Toromo JJ, Apondi E, Nyandiko WM, Omollo M, Bakari S, Aluoch J, et al. “I have never talked to anyone to free my mind” – challenges surrounding status disclosure to adolescents contribute to their disengagement from HIV care: a qualitative study in western Kenya. BMC Public Health. 2022 Dec 4; 22(1): 1122: |
| [10] | Edun O, Shenderovich Y, Zhou S, Toska E, Okell L, Eaton JW, et al. Predictors and consequences of HIV status disclosure to adolescents living with HIV in Eastern Cape, South Africa: a prospective cohort study. J Int AIDS Soc. 2022 May 11; 25(5): |
| [11] | Cyrus M, N N, C M, D W. Adolescent experiences, perceptions, and preferences for the process of HIV status disclosure in Kenya. Front Public Heal . 2023 Dec 1; 11: |
| [12] | Mokgatle M, Madiba S. Community Perceptions of HIV Stigma, Discriminatory Attitudes, and Disclosure Concerns: A Health Facility-Based Study in Selected Health Districts of South Africa. Int J Environ Res Public Health. 2023 Jul 18; 20(14): 6389: |
| [13] | Mugo M, N N, C M, D W. Adolescent experiences, perceptions, and preferences for the process of HIV status disclosure in Kenya. 2023; (December): 1–11. |
| [14] | Opiyo RO, Ndunyu LN, Onyango PO. Effect of Caregivers’ HIV Disclosure Training on Pediatric HIV Status Disclosure and ART Adherence in Homa Bay County, Kenya: A Comparative Longitudinal Study. J Heal Med Nurs. 2022; 8(1): 20. Available from: |
| [15] | KNBS. Kenya Population Based HIV Impact Assesment. 2019; 1–7. |
| [16] | D. Onguru, Obiero J, Onguru D, Ogolla S, Mboya E. Determinants of HIV Status Disclosure among Adolescents in Bondo Sub-county of Siaya County in Kenya. 2021; 5(3): 1–17. Available from: |
| [17] |
NSDCC. Kenya AIDS Response Progress Report 2025. 2025; Available from:
https://nsdcc.go.ke/wp-content/uploads/2025/11/Kenya-AIDS-Progress-Report-2025.pdf |
| [18] | NSDCC. A decade of progress Report: Kenya. 2023; 280. Available from: |
| [19] | Poteat T, Ackerman B, Diouf D, Ceesay N, Mothopeng T, Odette KZ, et al. HIV prevalence and behavioral and psychosocial factors among transgender women and cisgender men who have sex with men in 8 African countries: A cross-sectional analysis. PLoS Med . 2017 Nov; 14(11): e1002422: |
| [20] | Vreeman., Scanlon ML, Marete I, Mwangi A, Thomas, S. Inui CIM & WMN. A cross-sectional study of disclosure of HIV status to children and adolescents in Western Kenya. PLoS One. 2019 Jan 27; 9(1): 1–10: |
| [21] | Namukwaya S, Paparini S, Seeley J, Bernays S. “How Do We Start? And How Will They React?” Disclosing to Young People with Perinatally Acquired HIV in Uganda. Front public Heal. 2019; 5: 343. |
| [22] | Kimera E, Vindevogel S, Reynaert D, Justice M, Rubaihayo J, Maeyer J De, et al. Experiences and effects of HIV-related stigma among youth living with HIV / AIDS in Western Uganda: A photovoice study. 2020; 1–21. Available from: |
| [23] | NASCOP. Integrated Guidelines for Prevention, Treatment and Management of HIV, Sexually Transmitted Infections and Viral Hepatitis. 2026; Available from: |
| [24] | Chaudoir, Fisher JD. Understanding HIV disclosure: A review and application of the Disclosure Processes Model. 2011; 136(2): 236–56: |
| [25] | Puffer ES, Finnegan A, Schenk K, Langhaug L, Rusakaniko S, Choi Y, et al. Comparing fears about paediatric HIV disclosure to the lived experiences of parents and guardians: a prospective cohort study. Psychol Health . 2023 Dec 2; 38(12): 1587–605: |
| [26] |
Flay, Brian R, Frank J Snyder JP. The Theory of Triadic Influence (TTI). 2009; 451–510. Available from:
https://www.researchgate.net/publication/224942235_The_Theory_of_Triadic_Influence |
| [27] | Johnson-Peretz J, Onyango A, Akatukwasa C, Atwine F, Owino L, Arunga TMO, et al. Youths’ strategies for HIV status disclosure in rural Kenya and Uganda: “You can’t just trust everyone.” SSM - Qual Res Heal . 2025 Dec; 8: 100650: |
| [28] | Johnson‐Peretz J, Lebu S, Akatukwasa C, Getahun M, Ruel T, Lee J, et al. “I was still very young”: agency, stigma and HIV care strategies at school, baseline results of a qualitative study among youth in rural Kenya and Uganda. J Int AIDS Soc . 2022 Jul 12; 25(S1): |
| [29] | Bibace, Roger; Walsh ME. The Development of Children’s Concepts of Health and Illness. 1980; Available from: |
| [30] | NSDCC. Kenya HIV Prevention and Treatment Guidelines, 2022 Edition. 2022. |
| [31] | Beauchamp MR, Crawford KL, Jackson B. Social cognitive theory and physical activity: Mechanisms of behavior change, critique, and legacy. Psychol Sport Exerc . 2019 May; 42: 110–7: |
| [32] | Magill EB, Nyandiko W, Baum A, Aluoch J, Chory A, Ashimoshi C, et al. Factors associated with caregiver compliance to an HIV disclosure intervention and its effect on HIV and mental health outcomes among children living with HIV: post-hoc instrumental variable-based analysis of a cluster randomized trial in Eldoret, Kenya. Front Public Heal . 2023 May 5; 11: |
| [33] | Ampath. HADITHI: The story of disclosure among adolescents with HIV. 2025; Available from: |
| [34] | Epée Ngoué E, Isabelle MN, Guylaine DN, Jeannette, Arielle ST, Jocelyn TN, et al. Determinants of HIV Status Disclosure to Children and Adolescents in Cameroon: A Case-Control Study. Heal Res Africa. 2026; 4(1): 7–15. |
| [35] |
Erving Goffman. Stigma theory. 2020; Available from:
https://www.howcommunicationworks.com/blog/2020/12/31/goffman-stigma-spoiled-social-identity |
| [36] | Roura M, Urassa M, Busza J, Mbata D, Wringe A, Zaba B. Scaling up stigma ? The effects of antiretroviral roll- out on stigma and HIV testing. Early evidence from rural Tanzania. 2019; 308–12. |
| [37] | Wiggins L, O’Malley G, Wagner AD, Mutisya I, Wilson KS, Lawrence S, et al. ‘They can stigmatize you’: a qualitative assessment of the influence of school factors on engagement in care and medication adherence among adolescents with HIV in Western Kenya. Health Educ Res . 2022 Sep 23; 37(5): 355–63: |
APA Style
Obiero, O., Mpofu, L., Mwaniki, L. (2026). Determinants of HIV Status Disclosure to Adolescents in Western Kenya: Developing an Evidence-based Disclosure Guide. Social Sciences, 15(4), 181-195. https://doi.org/10.11648/j.ss.20261504.14
ACS Style
Obiero, O.; Mpofu, L.; Mwaniki, L. Determinants of HIV Status Disclosure to Adolescents in Western Kenya: Developing an Evidence-based Disclosure Guide. Soc. Sci. 2026, 15(4), 181-195. doi: 10.11648/j.ss.20261504.14
@article{10.11648/j.ss.20261504.14,
author = {Ooko Obiero and Limkile Mpofu and Lawrence Mwaniki},
title = {Determinants of HIV Status Disclosure to Adolescents in Western Kenya: Developing an Evidence-based Disclosure Guide},
journal = {Social Sciences},
volume = {15},
number = {4},
pages = {181-195},
doi = {10.11648/j.ss.20261504.14},
url = {https://doi.org/10.11648/j.ss.20261504.14},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ss.20261504.14},
abstract = {HIV status disclosure to adolescents living with Human Immunodeficiency Virus (ALHIV) is essential for adherence to ART treatment and psychosocial well‑being yet it remains delayed in high‑burden settings. This study examined the rate and timing of HIV status disclosure and identified individual, familial, and socio-cultural determinants influencing HIV status disclosure to adolescents in Western Kenya. A convergent parallel mixed?methods design was used. Quantitative data were collected from 310 caregivers of ALHIV aged 10–19 years attending three health facilities in Bondo Sub?County using structured questionnaires. Qualitative data were obtained through eight focus group discussions (64 caregivers) and 10 key informant interviews with healthcare providers. Quantitative data were analysed using multivariate logistic regression with quadratic age terms, while qualitative data were analysed thematically. Integration was achieved through joint displays and a weaving approach. The HIV status disclosure rate was 74.5%, yet disclosure was delayed in early adolescence: only 1.8% of adolescents aged 10–12 years had been disclosed to, compared with 60.5% of those aged 13–14 years and 96.3% of those aged 15–19 years (mean disclosure age: 11.8 years). Age demonstrated a strong non?linear association with disclosure (quadratic aOR = 0.70, 95% CI: 0.59–0.83; p < 0.001). Independent predictors of disclosure included caregiver training the strongest modifiable determinant (aOR = 15.61)—caregiver confidence in discussing HIV (aOR = 2.42), access to adolescent peer support groups (aOR = 3.33), facility of care (aOR = 2.96), and perceived adolescent emotional maturity (aOR = 1.52), while fear of psychological distress emerged as the dominant barrier (aOR = 0.27). Although 34.6% of adolescents experienced initial distress following disclosure, 93.9% demonstrated improved ART adherence and 92.6% improved emotional well-being. Findings showed HIV disclosure decisions depended on caregiver capacity and health system support. In Western Kenya, adolescent disclosure remains delayed beyond guideline recommendations, with age serving as a threshold. Effective disclosure requires alignment between adolescent emotional readiness, caregiver preparedness, and supportive health system structures. An evidence-based disclosure guide was developed comprising three-core components: readiness-based assessment integrated with caregiver capacity building, family-engaged disclosure planning, and health-system enabling with structured post-disclosure support. This framework reconceptualises HIV disclosure from an age-driven expectation to a system-dependent process. There is need to implement structured HIV disclosure approaches that integrate readiness-based assessment, systematic caregiver capacity building, and strengthened adolescent peer support systems. Disclosure should be initiated earlier through individualised, and informed planning. Lastly, trauma-informed post-disclosure follow-up should be embedded within routine care to address initial distress and sustain improvements in adherence and emotional well-being.},
year = {2026}
}
TY - JOUR T1 - Determinants of HIV Status Disclosure to Adolescents in Western Kenya: Developing an Evidence-based Disclosure Guide AU - Ooko Obiero AU - Limkile Mpofu AU - Lawrence Mwaniki Y1 - 2026/07/27 PY - 2026 N1 - https://doi.org/10.11648/j.ss.20261504.14 DO - 10.11648/j.ss.20261504.14 T2 - Social Sciences JF - Social Sciences JO - Social Sciences SP - 181 EP - 195 PB - Science Publishing Group SN - 2326-988X UR - https://doi.org/10.11648/j.ss.20261504.14 AB - HIV status disclosure to adolescents living with Human Immunodeficiency Virus (ALHIV) is essential for adherence to ART treatment and psychosocial well‑being yet it remains delayed in high‑burden settings. This study examined the rate and timing of HIV status disclosure and identified individual, familial, and socio-cultural determinants influencing HIV status disclosure to adolescents in Western Kenya. A convergent parallel mixed?methods design was used. Quantitative data were collected from 310 caregivers of ALHIV aged 10–19 years attending three health facilities in Bondo Sub?County using structured questionnaires. Qualitative data were obtained through eight focus group discussions (64 caregivers) and 10 key informant interviews with healthcare providers. Quantitative data were analysed using multivariate logistic regression with quadratic age terms, while qualitative data were analysed thematically. Integration was achieved through joint displays and a weaving approach. The HIV status disclosure rate was 74.5%, yet disclosure was delayed in early adolescence: only 1.8% of adolescents aged 10–12 years had been disclosed to, compared with 60.5% of those aged 13–14 years and 96.3% of those aged 15–19 years (mean disclosure age: 11.8 years). Age demonstrated a strong non?linear association with disclosure (quadratic aOR = 0.70, 95% CI: 0.59–0.83; p < 0.001). Independent predictors of disclosure included caregiver training the strongest modifiable determinant (aOR = 15.61)—caregiver confidence in discussing HIV (aOR = 2.42), access to adolescent peer support groups (aOR = 3.33), facility of care (aOR = 2.96), and perceived adolescent emotional maturity (aOR = 1.52), while fear of psychological distress emerged as the dominant barrier (aOR = 0.27). Although 34.6% of adolescents experienced initial distress following disclosure, 93.9% demonstrated improved ART adherence and 92.6% improved emotional well-being. Findings showed HIV disclosure decisions depended on caregiver capacity and health system support. In Western Kenya, adolescent disclosure remains delayed beyond guideline recommendations, with age serving as a threshold. Effective disclosure requires alignment between adolescent emotional readiness, caregiver preparedness, and supportive health system structures. An evidence-based disclosure guide was developed comprising three-core components: readiness-based assessment integrated with caregiver capacity building, family-engaged disclosure planning, and health-system enabling with structured post-disclosure support. This framework reconceptualises HIV disclosure from an age-driven expectation to a system-dependent process. There is need to implement structured HIV disclosure approaches that integrate readiness-based assessment, systematic caregiver capacity building, and strengthened adolescent peer support systems. Disclosure should be initiated earlier through individualised, and informed planning. Lastly, trauma-informed post-disclosure follow-up should be embedded within routine care to address initial distress and sustain improvements in adherence and emotional well-being. VL - 15 IS - 4 ER -